Sugammadex is changing the paradigm in neuromuscular blockade in patients with myotonic dystrophy

J Perioper Pract. 2019 Oct;29(10):337-340. doi: 10.1177/1750458919838412. Epub 2019 Mar 19.
No abstract available

Keywords: Myotonic dystrophy type 1; Neuromuscular blockade reversal; Neuromuscular diseases; Rocuronium; Sugammadex.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anesthesia, General
  • Cholecystectomy, Laparoscopic / methods*
  • Humans
  • Male
  • Myotonic Dystrophy / surgery*
  • Neuromuscular Blockade*
  • Sugammadex / administration & dosage*
  • Treatment Outcome

Substances

  • Sugammadex